How Politics Became Every Hospital’s Brand Risk

Right before the 25th anniversary of 9/11, New York City released more than 170,000 pages of records showing that officials knew within weeks of the attacks that the air around Ground Zero was unsafe to breathe in, even as the public was told it was. The newly disclosed correspondence, including an October 2001 memo warning city officials of potential legal exposure, came alongside asbestos still being detected in lower Manhattan months after the attacks. The disclosure reminds us of a dynamic hospitals rarely get to choose: when government fails on public health, hospitals inherit the fallout in trust, for better or worse.

Public trust and reputation follows transparency

For most of the past century, the relationship between hospitals and government remained quiet and largely cooperative in matters of public research funding, wartime medical investment, and steady growth in federal grants.  However, a transparency failure like these 9/11 documents from New York City’s government, or a fight over federal research funding, can move public trust and institutional reputation before a hospital’s leadership has said a word.

Hospitals are already living this shift, and sometimes it works in their favor. The World Trade Center Health Program, created under the Zadroga Act, runs Clinical Centers of Excellence at Mount Sinai and NYU Langone, among other sites, providing free monitoring and treatment to responders and survivors. Over two decades, the two systems grew into something larger than treatment centers for 9/11-related illness: they became the institutions that the affected community trusted to tell them the truth, largely because the government took years to do the same. That kind of trust outlasts a single news cycle and serves as real, durable brand equity. It becomes an institution’s license to operate. The public and professional backing that lets a hospital keep functioning, recruiting and growing through periods of political turbulence.

Why academic medical centers carry the most risk

That same relationship between politics and hospital reputation can just as easily cut the other way. When the policy environment turns adversarial rather than merely absent, hospitals don’t inherit trust, they inherit risk, and the stakes reach well beyond any single institution. That’s especially true for academic medical centers, which train the next generation of physicians, conduct the bulk of the country’s clinical research, and anchor America’s global standing in medical innovation. That concentration is exactly what federal funding fights now put at risk, as cuts and disruptions to National Institutes of Health and National Science Foundation funding over the past two years demonstrate.

What Hopkins lost and how it responded

Strong legacy hospital brands can absorb these policy shocks for a while. Their reputations, built over decades, don’t erode overnight. Johns Hopkins University is a case in point on both fronts, as it saw the value of its multiyear federal research portfolio decline by more than $500 million in 2025, a 43% drop in federal funding and 28% fewer active research grants than the year before, and laid off roughly 110 employees in 2026, on top of more than 2,200 cuts in 2025. But Hopkins hasn’t just absorbed the hit — it has nearly doubled its spending on lobbyists since 2024 and launched a public campaign defending its research funding, evidence that at least one major system already treats policy exposure as a standing operational risk rather than a one-time emergency. 

Build a license to operate before the crisis

The lesson for hospital communications, government affairs, and brand teams is straightforward. In order to protect brand strength, political and funding developments belong on the same tracking dashboard as competitor moves and patient satisfaction scores, not filed away until a crisis forces a response. Hopkins has shown what that looks like in practice. While the rest of the sector has ground to make up for, from building a standing position on research funding, to government transparency before a crisis forces one out, and investing in the kind of institutional trust that outlasts any single administration, the kind that Mount Sinai and NYU Langone built over 20 years of consistent stakeholder engagement. That trust is a hospital’s brand equity, which functions as its license to operate. Institutions that have built it can absorb a funding fight or a transparency failure without losing the talent, patients or public backing they depend on. Institutions that haven’t are the ones that find out, usually too late, that brand strength was never just a marketing metric.

Hospitals didn’t design the political climate they now operate in, but they will be judged by how well they anticipate it. The institutions that track policy risk with the same discipline they apply to competitor moves and patient satisfaction today won’t just protect their brand strength. They’ll be the ones still setting the benchmark for trust the next time the system falls short.

Photo: Niyazz, Getty Images

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.